Bank7 (BSVN)
(Delayed Data from NSDQ)
$28.20 USD
+0.39 (1.40%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $27.93 -0.27 (-0.96%) 7:58 PM ET
1-Strong Buy of 5 1
B Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Bank7 Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 131 | 82 | 59 | 55 | 53 |
Cost Of Goods | 39 | 9 | 3 | 6 | 10 |
Gross Profit | 92 | 72 | 55 | 49 | 44 |
Selling & Adminstrative & Depr. & Amort Expenses | 55 | 33 | 25 | 23 | 28 |
Income After Depreciation & Amortization | 37 | 39 | 31 | 26 | 15 |
Non-Operating Income | NA | 0 | 0 | 0 | 0 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | 37 | 39 | 31 | 26 | 15 |
Income Taxes | 9 | 10 | 8 | 7 | 7 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 28 | 30 | 23 | 19 | 8 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 28 | 30 | 23 | 19 | 8 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 39 | 41 | 32 | 27 | 16 |
Depreciation & Amortization (Cash Flow) | 2 | 2 | 1 | 1 | 1 |
Income After Depreciation & Amortization | 37 | 39 | 31 | 26 | 15 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 9.26 | 9.21 | 9.09 | 9.38 | 10.15 |
Diluted EPS Before Non-Recurring Items | 3.05 | 3.22 | 2.60 | 2.05 | 1.96 |
Diluted Net EPS (GAAP) | 3.05 | 3.22 | 2.55 | 2.05 | 0.81 |
Fiscal Year end for Bank7 Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 39.17 | 32.73 | 30.84 | 28.05 | 26.19 |
Cost Of Goods | 11.10 | 10.98 | 9.54 | 7.37 | 5.08 |
Gross Profit | 28.06 | 21.75 | 21.29 | 20.68 | 21.11 |
SG&A, R&D, and Dept/Amort Expenses | 26.50 | 11.55 | 8.39 | 8.12 | 9.75 |
Income After SG&A, R&D, and Dept/Amort Expenses | 1.56 | 10.20 | 12.90 | 12.56 | 11.36 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 1.56 | 10.20 | 12.90 | 12.55 | 11.36 |
Income Taxes | 0.49 | 2.35 | 3.16 | 2.95 | 2.97 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 1.07 | 7.85 | 9.75 | 9.61 | 8.39 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 1.07 | 7.85 | 9.75 | 9.61 | 8.39 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 9.28 | 9.27 | 9.25 | 9.26 | 9.23 |
Diluted EPS Before Non-Recurring Items | 0.12 | 0.85 | 1.05 | 1.04 | 0.91 |
Diluted Net EPS (GAAP) | 0.11 | 0.85 | 1.05 | 1.04 | 0.92 |